All subordinate units of the group commend advanced
Release time:
2021-02-10
1# On May 25, at the 2020 work summary meeting held by Yunnan Jianfeng Cement Company, Zhou Jiping made a work report on behalf of Yunnan Jianfeng management team to summarize the production and operation situation in 2020. In 2020, Yunnan Peak overcame the impact of the epidemic and regional new capacity, in the difficult market environment, bucked the trend to create the highest sales in the eight years since the establishment of the plant, to achieve the only sales in southwest Yunnan over last year, the only receivables cleared of the same industry enterprises. Zhou Jiping objectively analyzed the problems and deficiencies in the work, and combined with the actual work in 2020, put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2021. Liu Shenghua, the new general manager of Yunnan Peak, has arranged the work for 2021 in combination with the actual production of Yunnan Peak. The
meeting commended the advanced collectives and individuals in 2020. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, and in the face of new production and operation tasks, Strive to catch up and surpass head-on and reach a new high. At the summary and commendation meeting of the pharmaceutical company held on October 3, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, made an annual work report on behalf of the management team of the pharmaceutical company, he reviewed the main work in 2020 from the aspects of epidemic prevention and control and resumption of production, safety and environmental protection management, product development and technological innovation, marketing management, standardizing production and operation behavior, talent recruitment and training, brand promotion of companies and products, and the work of the party and government work group, and analyzed the industry policy and development trend in 2021. He pointed out that the pharmaceutical industry will still have to face strict industry regulatory policies and severe market competition in 2021, and "recovery, innovation, integration and compliance" will be the key words of China's pharmaceutical economy in 2021. The pharmaceutical company will focus on the overall goal of "reducing costs, expanding the market, increasing speed, and creating benefits", and carry out various production and operation management work in an orderly manner. Jiang Xiaomeng, chairman of
Group Company and chairman of Pharmaceutical Company, attended the meeting. On behalf of the Group Company, he congratulated the advanced collectives and individuals who were commended, affirmed the work of Jianfeng Pharmaceutical in 2020, and put forward requirements for the work of Pharmaceutical Company in 2021. He requested that pharmaceutical companies should create three advantages and create new performance from three aspects: innovative research and development, preparation costs, and API characteristics; make breakthroughs in innovative marketing, management capabilities and thinking, and further refresh marketing capabilities and labor productivity. Reduce costs. At the same time, he hopes that all employees of the pharmaceutical industry will have a sense of urgency, mission and crisis, and complete various indicators of the pharmaceutical company through the efforts of all parties. At the
meeting, the pharmaceutical company awarded the advanced collectives and individuals in 2020. On behalf of the pharmaceutical company, Huang Jinlong signed a new year's economic target responsibility system with the heads of its subordinate enterprises.
This meeting was presided over by Jin Huazhong, Secretary of the Party Committee of Pharmaceutical Company, and summarized the contents of the meeting.
2On the 4th, Guizhou Huangping Jianfeng Cement Company held a summary commendation meeting to commend the advanced collectives and individuals in 2020 and convey the spirit of the group's annual business analysis meeting and summary commendation meeting. Huang Ping Jianfeng Manufacturing Department Yu Wang Yang, Purchasing Department Yang Changyuan and Marketing Department Long Liwei spoke at the meeting as advanced representatives.
2
On the 5th, at the summary commendation meeting held by daye peak cement company, Zhang Fengliang, deputy general manager of the group company and general manager of daye peak cement company, made a 2020 work report, summarizing the progress made by daye peak during the 13th Five-Year Plan period from the aspects of increasing per capita labor productivity year by year, continuous growth of employee income, increasingly standardized enterprise management, and effective technological transformation. He analyzed the challenges brought about by the changes in the external environment of the cement industry in 2021, as well as the shortcomings in the internal management of the enterprise, and required middle-level managers not only to learn from others and learn from others, but also to learn management knowledge and improve themselves. Management ability, always pay attention to the development of domestic and foreign industries, and know their own equipment and technical level; all employees should have a strong sense of responsibility and mission, have passion for work, transmit positive energy, do not care about it, base on their own work, earnestly safeguard the interests of the enterprise, work conscientiously, unite sincerely, and achieve the same progress and common development of enterprises and individuals. Themeeting also awarded honorary certificates to advanced individuals and collectives, and advanced representatives Ke Quanjun and Liu Lin made speeches.
2# On the afternoon of July 7, at the summary and commendation meeting of Jianfeng Health Technology Company, employees gathered together to sum up the past and talk about the future. The peak health management team presented awards to advanced collectives, outstanding employees and "1 1" direct purchase outstanding marketers. Yin Zhiwu, general manager of Jianfeng Health, said that in 2021, Jianfeng Health will focus on the business idea of developing health products (health food and ordinary food), supplemented by plant extracts and Chinese herbal pieces. It will make concerted efforts to create the fist products of health products business, focus on the investment promotion agency sector, and complement entrusted processing, group purchase and retail terminals. Organize production and operation in strict accordance with GMP requirements and food regulations; Strictly pay attention to safety and environmental protection work, strive to be a safe and environmentally friendly accident-free factory.
2 On the 8th, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made an annual work report for 2020, summarizing the outstanding highlights and achievements of the marketing department, production department, technology department and comprehensive finance department, and arranging the specific work ideas and efforts for 2021. Yu Jianhong, general manager of
Group Company, attended the meeting and presented awards to advanced collectives and outstanding employees. He congratulated the advanced collectives and individuals, affirmed the achievements of the cable company in 2020, and put forward requirements for the work of the cable company in 2021. He hopes that all employees of the cable company will establish confidence and make persistent efforts to believe that they can cope with external difficulties and have the ability to enable the cable company to achieve better benefits; further strengthen management and improve the level of technology; further increase market acceptance capabilities and improve technology Level, expand customer coverage, and enhance the reputation of cable companies. (qi jianmei, ni yingzhen, pan yi, wang yuhua, xu ying, zhou guangliang, xu feng, huang yuan)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page